Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-007485

Chief Legal Officer gave up 1,308 shares (to pay taxes)

  • Chief Legal Officer acquired 3,875 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ali-Jackson Kamil Chief Legal Officer 2019-02-01 Option exercise +3,875 83,520 D
Ali-Jackson Kamil Chief Legal Officer 2019-02-01 Shares withheld for taxes −1,308 $6.96 $9,104 82,212 D
Derivatives
Ali-Jackson Kamil Chief Legal Officer 2019-02-01 Option exercise · Restricted Stock Units −3,875 11,625 D
Loading xslF345X03/doc4.xml…